Globus Medical (GMED) Long-Term Investments (2013 - 2026)

Globus Medical's Long-Term Investments history runs 14 years deep, the most recent figure standing at $169.4 million for Q1 2026.

• Quarterly Long-Term Investments changed N/A year-over-year to $169.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $169.4 million (changed N/A YoY) and the FY2025 annual result came in at $71.8 million, up 8.6% from the prior year.
• Long-Term Investments was $169.4 million for Q1 2026 at Globus Medical, up from $71.8 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $546.9 million in Q1 2022 and bottomed at $12.3 million in Q3 2024.
• A 5-year average of $243.9 million and a median of $169.4 million in 2026 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2024 — Long-Term Investments slumped 95.54% — and 2025, when it surged 35.68%.
• Globus Medical's Long-Term Investments stood at $495.9 million in 2022, then plunged by 84.79% to $75.4 million in 2023, then retreated by 12.32% to $66.1 million in 2024, then climbed by 8.6% to $71.8 million in 2025, then surged by 135.92% to $169.4 million in 2026.
• Business Quant data shows GMED's Long-Term Investments at $169.4 million in Q1 2026, $71.8 million in Q4 2025, and $16.7 million in Q3 2025.